IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Glaxosmithkline

Q2 2016 vs Q3 2016

Comparing institutional holders between quarters

Quarters

Q3 2016Q2 2016Q1 2016Q4 2015Q3 2015
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
Boston Common Asset Management, LLC
UNCHANGED
Shares37,160 from 37,160
Change0 (0%)
Value$793 (-$4)
Filed 2016-11-04
Status
Boston Common Asset Management, LLC
UNCHANGED37,16037,16000%$797$793-$42016-11-04
Showing 1 of 1 institutions